Xenon Pharmaceuticals (XENE) Asset Utilization Ratio (2014 - 2025)

Xenon Pharmaceuticals (XENE) posted quarterly Asset Utilization Ratio of 0.01 for Q4 2025, up 3.31% quarter-over-quarter from 0.01 in Q3 2025.

Xenon Pharmaceuticals (XENE) Asset Utilization Ratio (2014 - 2025) Analysis & Trends

Xenon Pharmaceuticals (XENE) has reported Asset Utilization Ratio for 10 consecutive years, with 0.01 the latest figure, recorded in Q4 2025.

In Q4 2025, Asset Utilization Ratio changed N/A year-over-year to 0.01; the TTM figure through Dec 2025 stood at 0.01 (changed N/A YoY), while the FY2025 annual figure was 0.01, changed N/A from the prior year.
Asset Utilization Ratio grew to 0.01 in Q4 2025 per XENE's latest filing, from 0.01 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 0.12 in Q1 2021 and bottomed at 0.0 in Q2 2024.
Historically, Asset Utilization Ratio has averaged 0.03 across 4 years, with a median of 0.01 in 2022.
Annual changes were most pronounced in 2022 — Asset Utilization Ratio tumbled 77.41% — and 2025, when it soared 7126.86%.
Xenon Pharmaceuticals' Asset Utilization Ratio stood at 0.04 in 2021, then sank by 72.03% to 0.01 in 2022, then plunged by 98.81% to 0.0 in 2024, then jumped by 8155.05% to 0.01 in 2025.
Business Quant data shows XENE's Asset Utilization Ratio at 0.01 in Q4 2025, 0.01 in Q3 2025, and 0.01 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.38
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.69
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	186.67
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.13
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	0.90
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	0.54
10	Xenon Pharmaceuticals	6.03 Bn	6.03 Bn	-	-

Download Data